Sentinel lymph node biopsy in breast cancer patients - Results and experience after 500 sentinel lymph node biopsies;Die sentinellymphknotenbiopsie beim mammakarzinom - Ergebnisse und erfahrungen nach 500 sentinellymphknotenbiopsien

Gynakologisch-geburtshilfliche Rundschau

Volumn 43, Issue 2, 2003, Pages 98-103

  Reitsamer, Roland ^a   Menzel, C ^a   Peintinger, F ^d   Cimpoca, W ^a   Gluck S ^a   Sinzinger, G ^a   Rettenbacher, L ^b   Kassmann H ^b   Hoffmann, A ^b   Prokop, E ^c   Strasser, F ^c   Kiesler, J ^c   Hutarew, G ^c   Dietze, O ^c  

^a Landesklinik Spezielle G   (Austria)

^b Abt F Nuklearmed und Endokrinol   (Austria)

^c Inst fur E   (Austria)

^d Abt fur Geburtshilfe/Gynakol   (Austria)

Author keywords

Axillary dissection; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT; SERUM ALBUMIN TC 99M;

ADJUVANT CHEMOTHERAPY; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER LOCALIZATION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENTINEL LYMPH NODE BIOPSY;

EID: 0037243636     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069162     Document Type: Article

References (25)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398.
2. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-340.
3. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida ST, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-1867.
4. Peintinger F, Reitsamer R, Piswanger C, Stranzl H: Quality of life and arm mobility after axillary lymph node dissection versus sentinel lymph node biopsy. Breast Cancer Res Treat 2001;69:220.
5. Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R: Long-term morbidity following axillary dissection in breast cancer patients - Clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000;64:275-286.
6. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
7. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, van Diest PJ, Teule GJ: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-368.
8. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer: A multi-center validation study. N Engl J Med 1998;339:941-946.
9. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
10. Meyer JS: Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen. J Surg Oncol 1998;69:212-218.
11. Turner RR, Ollila DW, Stern S, Giuliano AE: Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999;23:263-267.
12. Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV: Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 1985;72:365-367.
13. Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS, Sabates B, Ketcham AS: Total axillary lymphadenectomy in the management of breast cancer. Arch Surg 1991;126:1336-1342.
14. Cox CE, Salud CJ, Cantor A, Bass SS, Peltz ES, Ebert MD, Nguyen K, Reintgen DS: Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg. 2001;193:593-600.
15. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E: Comparison of subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labelled human albumin for identification of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 2001;69:219.
16. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, Farley DR, Heller R, Conant E, Orel SG, Lawton T, Fraker DL, Czerniecki BJ: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000;88:2540-2545.
17. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherypy for breast cancer. J Clin Oncol 2000;18:3480-3486.
18. Nason KS, Anderson BO, Byrd DR, Dunnwald LK, Eary JF, Mankoff DA, Livingston R, Schmidt RA, Jewell KD, Yeung RS, Moe RE: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187-2194.
19. Donnelly J, Parham DM, Hickish T, Chan HY, Skene AI: Axillary lymph node scarring and the association with tumor response following neoadjuvant chemoendocrine therapy for breast cancer. Breast 2001;10:61-66.
20. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA: Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 2000;24:1266-1272.
21. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999;230:72-78.
22. Fernandez A, Cortes M, Benito E, Azpeitia D, Prieto L, Moreno A, Ricart Y, Mora J, Escobedo A, Martin Comin J: Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 2001;22:361-366.
23. Haid A, Tausch C, Lang A, Lutz J, Fritzsche H, Peschina W, Breitfellner G, Sega W, Aufschnaiter M, Sturn H, Zimmermann G: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 2001;92:1080-1084.
24. Schrenk P, Wayand W: Sentinelnode biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001;357:122.
25. Schwartz GF, Giuliano AE, Veronesi U, the Consensus Conference Committee: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542-2551.